Skip to main content
OpenTrials
Completed

NCT Number: NCT02364674

Transplant Optimization Using Functional Imaging

The objective of this study is to detect Bronchiolitis Obliterans Syndrome (BOS) in an early stage using the outcome parameters generated by Functional Respiratory Imaging (FRI). Robust and automated segmentation algorithms will be developed for these parameters, focusing on quantitative computed tomography (CT) image analyses to provide the physician a more sensitive diagnostics tool. The evolution of BOS over time will be monitored using non-rigid image registration methods.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bronchiolitis Obliterans Bronchial Diseases Bronchiolitis Bronchitis Lung Diseases Lung Diseases, Obstructive Lung Transplant Rejection Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Columbia University Medical Center, New York, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female patient ≥ 18 years old
  • Written informed consent obtained
  • Patient who had undergone a lung transplant a year ago or more.
  • Female patient of childbearing potential who confirm that a contraception method was used at least 14 days before visit 1 and will continue to use a contraception method during the study
  • The patient must be able to perform the lung monitoring at home.

Exclusion criteria

  • Pregnant or lactating female
  • Known history of or active airways or anastomotic complications requiring intervention such as stenting or dilation

Treatment and study plan

High Resolution Computed Tomography scan

Radiation

a HRCT scan at Functional Residual Capacity (FRC) and Total Lung Capacity (TLC) will be taken on visit 1, visit 2, visit 3, visit 4 and visit 5.

An Upper Airway (UA) scan will be taken on visit 1.

Other names: HRCT scan

Primary outcomes

  1. Airway Volume (iVaw)

    Time frame: 12 months

    Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

  2. Airway Resistance (iRaw)

    Time frame: 12 months

    Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

  3. Specific Airway Volume (siVaw)

    Time frame: 12 months

    Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

  4. Specific Airway Resistance (siRaw)

    Time frame: 12 months

    Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

  5. Lobe volumes (iVlobes)

    Time frame: 12 months

    Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

  6. Air trapping

    Time frame: 12 months

    Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

  7. Internal Lobar Airflow Distribution

    Time frame: 12 months

    Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

  8. Low Attenuation or Emphysema Score

    Time frame: 12 months

    Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

  9. Blood Vessel Density or Fibrosis Score

    Time frame: 12 months

    Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

  10. Airway Wall Thickness

    Time frame: 12 months

    Exploratory imaging endpoints: HRCT-scan will be taken at visit 1 - visit 5.

Sponsors and collaborators

Lead sponsor

FLUIDDA nv

Industry

Registry information

Acronym: TROFI

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Feb 18, 2015
Registry last updated
Mar 29, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.